Literature DB >> 19455184

Homozygosity for a null allele of COL3A1 results in recessive Ehlers-Danlos syndrome.

Aurélie Plancke1, Muriel Holder-Espinasse, Valérie Rigau, Sylvie Manouvrier, Mireille Claustres, Philippe Khau Van Kien.   

Abstract

So far, mutations in the human COL3A1 gene have been associated with the predominantly inherited Ehlers-Danlos syndrome (EDS), vascular type. Genotype-phenotype correlation perspectives collapsed, as haploinsufficiency, which was long suggested to confer a milder or unrecognized phenotype, was reported in four patients with a phenotype similar to that of vascular EDS. Here, we study a case of recessive EDS in a young consanguineous girl of healthy parents. She fulfilled the vascular EDS criteria for laboratory testing. Total sequencing of COL3A1 cDNA identified a homozygous nucleotide duplication (c.479dupT) resulting in a premature termination codon (p.Lys161GlnfsX45). Studies in genomic DNA showed that this mutation was inherited from each parent. The expression analysis (RT-PCR, quantitative-PCR, immunohistochemistry, WB) showed strong mRNA decay and an absence of type III collagen in the proband. The expected COL3A1 haploinsufficiency in her healthy ascendants did not lead to the manifestations of vascular EDS. This case provides evidence of a stochastic effect of COL3A1 haploinsufficiency in humans, which could be explained by the relation between nonsense-mediated mRNA decay efficiency and the resulting dominant-negative effect depending on the position of the mutation and/or modifying factors. It opens up new perspectives for the understanding of COL3A1 genotype-phenotype correlations, which is required while considering targeted therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455184      PMCID: PMC2986673          DOI: 10.1038/ejhg.2009.76

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  16 in total

1.  Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

2.  Targeting gene therapy for osteogenesis imperfecta.

Authors:  Darwin J Prockop
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

3.  The Human Collagen Mutation Database 1998.

Authors:  R Dalgleish
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

4.  Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK).

Authors:  P Beighton; A De Paepe; B Steinmann; P Tsipouras; R J Wenstrup
Journal:  Am J Med Genet       Date:  1998-04-28

5.  Inheritance of Ehlers-Danlos type IV syndrome.

Authors:  F M Pope; G R Martin; V A McKusick
Journal:  J Med Genet       Date:  1977-06       Impact factor: 6.318

Review 6.  Collagens: molecular biology, diseases, and potentials for therapy.

Authors:  D J Prockop; K I Kivirikko
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

7.  Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development.

Authors:  X Liu; H Wu; M Byrne; S Krane; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

8.  Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.

Authors:  U Schwarze; W I Schievink; E Petty; M R Jaff; D Babovic-Vuksanovic; K J Cherry; M Pepin; P H Byers
Journal:  Am J Hum Genet       Date:  2001-09-27       Impact factor: 11.025

9.  A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa.

Authors:  Matthias Titeux; Valérie Pendaries; Laure Tonasso; Audrey Décha; Christine Bodemer; Alain Hovnanian
Journal:  Hum Mutat       Date:  2008-02       Impact factor: 4.878

Review 10.  Collagens, modifying enzymes and their mutations in humans, flies and worms.

Authors:  Johanna Myllyharju; Kari I Kivirikko
Journal:  Trends Genet       Date:  2004-01       Impact factor: 11.639

View more
  16 in total

1.  The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome.

Authors:  T K Cooper; Q Zhong; M Krawczyk; H-J Tae; G A Müller; R Schubert; L A Myers; H C Dietz; M I Talan; W Briest
Journal:  Vet Pathol       Date:  2010-06-29       Impact factor: 2.221

2.  Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiency.

Authors:  Janine Meienberg; Marianne Rohrbach; Stefan Neuenschwander; Katharina Spanaus; Cecilia Giunta; Sira Alonso; Eliane Arnold; Caroline Henggeler; Stephan Regenass; Andrea Patrignani; Silvia Azzarello-Burri; Bernhard Steiner; Anders O H Nygren; Thierry Carrel; Beat Steinmann; Gábor Mátyás
Journal:  Eur J Hum Genet       Date:  2010-07-21       Impact factor: 4.246

Review 3.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

4.  Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts.

Authors:  Gerd A Müller; Uwe Hansen; Zhi Xu; Benjamin Griswold; Mark I Talan; Nazli B McDonnell; Wilfried Briest
Journal:  FASEB J       Date:  2011-10-28       Impact factor: 5.191

Review 5.  Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.

Authors:  Helena Kuivaniemi; Gerard Tromp
Journal:  Gene       Date:  2019-05-07       Impact factor: 3.688

6.  Ultrastructural scoring of skin biopsies for diagnosis of vascular Ehlers-Danlos syndrome.

Authors:  Kim-Thanh Ong; Henri Plauchu; Simone Peyrol; Elisabeth Roux; Elisabeth Errazuriz; Philippe Khau Van Kien; Brigitte Arbeille; Alain Gaulier; Gabriela Georgescou; Patrick Collignon; Dominique P Germain; Marie-Noëlle Gaveau; Jérôme Perdu; Stéphane Laurent; Patrick Bruneval; Pierre Boutouyrie
Journal:  Virchows Arch       Date:  2012-05-02       Impact factor: 4.064

Review 7.  GPR56 and the developing cerebral cortex: cells, matrix, and neuronal migration.

Authors:  Kathleen Singer; Rong Luo; Sung-Jin Jeong; Xianhua Piao
Journal:  Mol Neurobiol       Date:  2012-09-22       Impact factor: 5.590

8.  Molecular phenotyping and functional assessment of smooth muscle-like cells with pathogenic variants in aneurysm genes ACTA2, MYH11, SMAD3 and FBN1.

Authors:  Joyce Burger; Natalija Bogunovic; Nathalie P de Wagenaar; Hui Liu; Nicole van Vliet; Arne IJpma; Alessandra Maugeri; Dimitra Micha; Hence J M Verhagen; Timo L M Ten Hagen; Danielle Majoor-Krakauer; Ingrid van der Pluijm; Jeroen Essers; Kak K Yeung
Journal:  Hum Mol Genet       Date:  2021-11-16       Impact factor: 6.150

9.  Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers-Danlos syndrome.

Authors:  Lee B Smith; Patrick W F Hadoke; Emma Dyer; Martin A Denvir; David Brownstein; Eileen Miller; Nancy Nelson; Sara Wells; Michael Cheeseman; Andy Greenfield
Journal:  Cardiovasc Res       Date:  2010-11-10       Impact factor: 10.787

10.  Loss of Col3a1, the gene for Ehlers-Danlos syndrome type IV, results in neocortical dyslamination.

Authors:  Sung-Jin Jeong; Shihong Li; Rong Luo; Natalie Strokes; Xianhua Piao
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.